Warby Parker (WRBY) Teardown: Numbers, Model, Bear Case

$871.9 million in FY2025 revenue. Average revenue per customer up 23% in three years. The company's first full year with positive diluted EPS, at $0.01. Operating cash flow crossing $100 million for the first time at $110.8M. By most reads, Warby Parker is marching toward the profitability that DTC brand skeptics said would never arrive.

Then you look at the full-year GAAP operating line: -$5.3M. Still negative. Year 15 of the company's existence. Every year of its life as a public company, the operating loss has been negative.

That is the tension at the centre of this teardown. The brand is real. The pricing power is real. The operational improvement is real. But here is where most reads go wrong, including the obvious prescription to "raise the 54% gross margin." Warby's gross-margin compression is largely structural and deliberate: in-store optometrist payroll and store occupancy land in cost of goods, so every new store drags reported gross margin until it matures, and the company is intentionally trading first-order margin for lifetime value (eye exams up 30% a year, contacts, higher-spend insurance cohorts). The Street knows this; its price targets run from $19 to $35 and the debate is not gross margin at all. The real question is whether store productivity and the Google AI-glasses optionality can carry growth now that e-commerce, the original DTC engine, has turned negative.

This is the teardown of a beloved brand with genuine pricing power that, 15 years in, still has not proven it can make money on a full-year GAAP basis.

Section 1 - The snapshot

Metric	FY2025	Q1 FY2026	Q1 FY2025
Revenue	$871.9M	$242.4M	$223.8M
Revenue YoY	+13.0%	+8.3%	n/a
Gross margin	54.0%	54.0%	56.3%
Operating income (loss)	-$5.3M (-0.6%)	$1.7M (0.7%)	$2.5M (1.1%)
Diluted EPS	$0.01	$0.03	$0.03
Adjusted EBITDA	$95.2M (10.9%)	$29.6M (12.2%)	n/a
Operating cash flow	$110.8M	$24.5M	n/a
Active customers (TTM)	2.689M	2.690M	n/a
ARPC	$324	~$331 (TTM)	~$307
Store count	323	337	298
Cash	$286.4M	$288.2M	n/a
Long-term debt	$0 funded	$0 funded	n/a

The five-year arc:

Fiscal year	Revenue	YoY growth	Gross margin	Operating margin	Diluted EPS	OCF
FY2021	$540.8M	n/a	58.8%	-26.6%	-$2.21	-$32.0M
FY2022	$598.1M	+10.6%	57.0%	-18.6%	-$0.96	$10.4M
FY2023	$669.8M	+12.0%	54.5%	-10.7%	-$0.54	$61.0M
FY2024	$771.3M	+15.2%	55.3%	-3.9%	-$0.17	$98.7M
FY2025	$871.9M	+13.0%	54.0%	-0.6%	$0.01	$110.8M

Section 2 - The business model: how Warby Parker actually makes money

Warby Parker is not a wholesale eyewear brand. It is not on EssilorLuxottica's shelf. It is not on Amazon. It sells directly through its own website and its own stores - 337 as of Q1 FY2026, up from 161 at the end of FY2021. Every transaction goes through Warby Parker's own channel. That structure is both the source of the gross margin and the source of the capital intensity.

The model has three interlocking pieces. First, Warby Parker designs its own frames and owns a vertically integrated supply chain with more than 30 factory partners (reduced from a more China-concentrated base in prior years; the company is actively diversifying). Frames start at $95 including prescription lenses - a price point that was genuinely disruptive in 2010 and remains below the mainstream optical retail average. Second, the company operates owned optical laboratories that cut and coat prescription lenses domestically, giving it cost control over the most complex part of the value chain and enabling the quality claims the brand is built on. Third, the physical store network now functions as the primary acquisition and upsell engine: 285 of 323 stores (88.2%) offer in-person eye exams, performed by employed or contracted optometrists. The exam visit drives contacts orders and progressive-lens upgrades that would never happen in a purely online transaction.

Revenue in FY2025 broke down as: eyewear $719.1M (82.5% of total), contacts $97.2M (11.1%), and eye care services $55.7M (6.4%). Contacts grew +23.4% YoY in FY2025 and eye care grew +37.5% YoY - both meaningfully faster than eyewear (+8.7%). The mix shift matters because contacts and eye care carry lower gross margins than eyewear, which is one of the three structural drivers of gross margin compression over the period. Marketing spend was $110.2M in FY2025 (12.6% of revenue), and the company added 175,000 net new Active Customers (+7.0%) to reach 2.689M. The Home Try-On program - long a signature of the DTC playbook - was sunset in Q4 FY2025 to reduce reverse-logistics costs.

The question most operators should be asking about this model: where does the margin expansion come from once the store fleet matures? The answer management has given is precision progressives (higher ASP), contacts bundling (repeat purchase cadence), and eye care (high LTV from annual exam visits). The ARPC data validates that those mechanisms are working. The gross margin data shows they have not yet overcome the structural cost of running the store and exam infrastructure.

Here is what the brand's cultural gravity looks like from the consumer side. These videos are social signals and sentiment data, not load-bearing financial facts.

@dmv.speechie

Thanks @Warby Parker - I ❤️ you #warbyparker #warby #glasseshaul #glassesgirl #firsttimemom

♬ original sound - Sam | SLP • Mom • Lifestyle

@dmv.speechie (Sam | SLP, Mom, Lifestyle), 76.9K plays, 693 likes. Organic customer love with no sponsorship tag. The brand earns this kind of content at the $95 price point; most optical brands cannot. Social signal only.

@aaliyaseika

New year NEW GLASSES? 🤓 which pair should we get? #eyeglasses #glasseshaul #eyeglassesforwomen #warbyparker @Warby Parker

♬ Sakura-lined street - KCNX

@aaliyaseika (Aaliya Seika), 43K plays, 4,009 likes. Frame haul with strong engagement rate. The glasses-haul category on TikTok drives top-of-funnel awareness that Warby Parker is not paying for directly. Social signal only.

Section 3 - Strengths: what a CFO can underwrite

1. ARPC expansion is three years of documented pricing power. From FY2022 to FY2025, Average Revenue per Active Customer grew from $263 to $324, a 23.2% increase across three consecutive fiscal years - every year, without exception. The mechanism is layered: precision progressives (launched April 2023, materially adopted by FY2024) carry higher ASPs than standard single-vision frames; in-store eye exams drive contacts prescriptions with 12-month replenishment cadence; and the FY2025 10-K confirms selective retail price increases on eyewear were implemented in Q2 FY2025. The CFO read: this is not a brand inflating prices once and hoping customers stay. Three years of compounding ARPC growth at 7-9% annually, against a 2.5-7% Active Customer count expansion, means Warby Parker is extracting more from each existing customer faster than it is adding new ones. That ratio matters. Source: WRBY 10-K FY2023, FY2024, FY2025.

2. A fortress balance sheet that no DTC peer matches. At March 31, 2026: $288.2M in cash and short-term investments, zero funded long-term debt, a $120M JPMorgan revolving credit facility (expandable to $175M) that was entirely undrawn, and a $100M share repurchase authorization approved in February 2026 - the company's first buyback since its IPO. Net cash of approximately $286M against a ~$3B equity capitalization is unusual for a company still posting GAAP operating losses. The cash pile earns roughly $8-10M in annual interest income, which is the single line item that pushed diluted EPS to $0.01 in FY2025. It also means the company can absorb multiple years of store-expansion capex without accessing capital markets. Source: 10-Q Q1 FY2026; WRBY 10-K FY2025; Q1 FY2026 earnings release.

3. 100% DTC means no wholesale dependency. Warby Parker does not route through EyeMed, VSP, LensCrafters, or any mass-channel optical retailer. Every sale is direct - online or in-store. That structure eliminates the channel concentration risks that have damaged other DTC brands (dependence on a single retailer, markdown pressure from wholesale partners, inability to control the end-customer relationship). Insurance-backed orders represented only 8.3% of FY2025 revenue, a deliberate and gradual ramp that is growing the mix without creating single-payer concentration. As we discussed in our Vital Farms teardown, the test of any premium brand model is whether the economics are yours to control or someone else's to compress. Warby Parker controls its distribution. Source: WRBY 10-K FY2025 Item 1.

4. Category tailwinds are multi-vector and durable. Eyewear is a medical necessity with a fashion overlay and a 2-year replenishment cycle - structurally different from discretionary apparel where a consumer can simply skip a season. A 2.689M Active Customer base on that cycle implies a $700M-$900M baseline revenue floor before any new customer acquisition. Blue-light awareness, aging demographics, and the expanding prescription population are long-term secular drivers. The AI eyewear partnership with Google, while financially opaque, puts Warby Parker in the same category-creation bet that Ray-Ban Meta is executing for EssilorLuxottica (Ray-Ban Meta passed 7M units sold per EssilorLuxottica's FY2025 commentary). The category is expanding, not contracting. Source: WRBY 10-K FY2025 Item 1; EssilorLuxottica FY2025 results (Feb 2026).

Section 4 - Weaknesses: the cracks in the filing

1. The company has never earned a positive GAAP operating income in its history - and the easy gains are gone. The profitability march from FY2021 to FY2025 - operating loss compressing from -$143.7M to -$5.3M - was driven almost entirely by SG&A as % of revenue falling from 85.3% to 54.6%. The largest single driver of that compression was the Founders Grant, a stock-compensation program for founding employees that generated tens of millions in annual SBC expense in FY2021-FY2023. By FY2024, the Founders Grant wind-down contributed a $23.2M year-over-year SBC reduction; by FY2025, the 10-K FY2025 confirms the program is "substantially completed." There is no equivalent SG&A efficiency driver waiting in the queue. But the next leg toward GAAP profitability does not run through gross-margin "recovery," as the obvious read suggests; that lever is largely closed (see the next point). It runs through operating efficiency at scale as the 337-store fleet matures, the high-LTV insurance and exam cohorts compounding, and the Google AI-glasses contribution. The FY2025 10-K still carries the language: the company "may be unable to achieve or sustain profitability." Source: WRBY 10-K FY2024 and FY2025.

2. Gross margin is structurally compressing, and tariffs are the current accelerant. Gross margin fell from 58.8% in FY2021 to 54.0% in FY2025 - a 480-basis-point decline over five years. The FY2024 recovery to 55.3% was a one-year exception driven by faster eyewear growth. Three forces are compressing the margin: (a) contacts and eye care revenue growing faster than eyewear, carrying lower margins; (b) exam-room doctor headcount and store occupancy costs scaling ahead of store maturation; and (c) since 2025, explicit tariff costs on Chinese-sourced frame components. The FY2025 10-K states verbatim: "We source components from suppliers located in China" and separately names February 2025 US tariff increases on Chinese imports as a current risk. Q4 FY2025 attributed gross margin compression to "tariff costs related to glasses." Q1 FY2026 attributed a -230 bps YoY decline to the same cause. But two of those three forces are deliberate: the doctor and occupancy cost and the exam-and-contacts mix are the company investing ahead of harvest, trading first-order margin for lifetime value. Only the tariff line is an unwanted shock. That is why the sell-side does not frame this as a margin to be "raised"; it frames it as a trajectory to be managed while store contribution and Adjusted EBITDA compound. The genuine risk is narrower: that the store cohorts do not mature into their contribution targets, or that e-commerce (down 4.1% in Q1 FY2026) keeps shrinking faster than stores can offset. Source: WRBY 10-K FY2025 Item 1A; Q4 FY2025 and Q1 FY2026 earnings releases; analyst commentary.

3. Active Customer growth decelerated sharply in Q1 FY2026. Active Customers peaked in growth rate at +9.3% YoY in Q3 FY2025 (2.66M accounts), then decelerated to +7.0% for full-year FY2025 (2.689M), and fell to +4.8% YoY in Q1 FY2026 (2.690M). From Q3 FY2025 to Q1 FY2026 - two quarters - the company added a net 30,000 Active Customers despite opening 14 new stores in Q1 FY2026 alone. Store productivity per new Active Customer added fell materially. The deceleration is the single most important deteriorating trend in the filing set because ARPC growth has a ceiling if the Active Customer base stops expanding - and 2.69M customers is not a number that represents saturation of any meaningful US demographic. Source: WRBY FY2024 and FY2025 10-K; Q1 FY2026 earnings release; Q2 and Q3 FY2025 earnings releases.

4. The Google AI-glasses partnership carries zero disclosed economics. Warby Parker added a new risk factor category in the FY2025 10-K - "AI and technology risk" - for the first time. The verbatim disclosure: "We are also developing products and services that integrate AI, such as the AI-powered smart glasses we are developing with Google." The 10-K does not disclose revenue share, unit economics, margin profile, capital commitment, launch timeline, or any financial terms of the partnership. Analysts have noted it as optionality; bears have noted it as potential distraction from the core operating-efficiency story. The category reference is EssilorLuxottica's Ray-Ban Meta (7M+ units sold), but those glasses are fashion sunglasses at $299-$329 without a prescription lens - a different product architecture than what Warby Parker would logically develop. Whether AI-glasses expand or cannibalize Warby Parker's core $95 prescription frame business is not a question the filing answers. Source: WRBY 10-K FY2025 Item 1A (citing the FY2025 10-K).

5. Store expansion is capital-intensive with a long maturation curve. Warby Parker spent $67.0M in capex in FY2025 to open 47 net new stores. The FY2025 10-K states that "approximately 65% of our retail stores have been opened in the last five years" and that expansion "will require significant expenditures before any substantial associated revenue is generated." Management has guided for approximately 50 more net new stores in FY2026, implying another $65-75M of capex in addition to the maintenance and lab investment. Each new store adds a multi-year lease obligation (operating lease liabilities stood at approximately $237.6M at March 31, 2026), doctor headcount, and occupancy cost before that store reaches contribution-margin maturity. The fixed-cost base builds faster than the revenue base when the store fleet is this young. Source: WRBY 10-K FY2025 Item 1A (verbatim quotes above); 10-Q Q1 FY2026 balance sheet.

Section 5 - Opportunities and threats

The opportunity side of the Warby Parker ledger is cleaner than the threat side right now, which is a reasonably good sign for a brand this far into its maturation.

The US store whitespace opportunity is real and management has internally sized it at over 900 potential locations. At 337 stores in Q1 FY2026, the company has penetrated roughly 37% of its own stated long-term opportunity. If store economics mature the way management projects - exam volume increases with age, contacts orders follow the exam, ARPC compounds as customers return - the next 500+ stores are the operating income story that the current financial statements do not yet show. The question is timing and capital cost.

The contacts and eye care mix shift is a genuine tailwind. Contacts grew +23.4% YoY in FY2025 and eye care +37.5%, both well ahead of eyewear's +8.7%. A customer who gets an exam at Warby Parker, buys frames, and then reorders contacts annually is structurally more valuable than a one-time frame buyer - and the exam visit creates the data relationship that makes retention possible. Insurance coverage expansion (8.3% of revenue in FY2025 and growing) adds a recurring-billing mechanic to a previously purely transactional relationship.

The Google AI-glasses partnership, with Google funding much of the cost (up to $75M of reimbursement plus up to $75M of optional equity per the Q1 FY2026 10-Q), is the one option the market is actively pricing. Co-CEO Dave Gilboa discussed the intelligent eyewear partnership publicly in May 2026:

@cnbc

Warby Parker co-CEO Dave Gilboa joins CNBC's "Squawk Box" to discuss the company's new intelligent eyewear frames in partnership with #Google and Samsung. Watch the full interview at the #linkinbio or the link on screen. #CNBC #AI #warbyparker #smartglasses

♬ original sound - cnbc - cnbc

@cnbc, 103.7K plays, 1,706 likes, 312 comments. Co-CEO Dave Gilboa discussing the Google/Samsung AI-powered smart glasses partnership on CNBC Squawk Box, May 2026. Social signal only - no financial disclosures in public appearances that are not also in SEC filings.

On the threat side, the tariff environment is the near-term margin wildcard. China is named in the 10-K as a primary sourcing geography for frame components. The February 2025 tariff increases on Chinese imports are explicitly cited as a cost driver in both Q4 FY2025 and Q1 FY2026 gross margin commentary. Supplier diversification takes time - the 10-K FY2025 acknowledges it is underway, but the near-term COGS impact of the China-to-elsewhere transition (higher per-unit costs from alternative suppliers, transition inefficiencies) may compress margins before diversification creates a structural improvement. The Adjusted EBITDA guidance for FY2026 of $117-119M (12.2% margin) implies management expects SG&A efficiency to offset the gross margin drag - but that is not gross margin recovery, it is gross margin deferral.

The deceleration of Active Customer growth is a structural threat that the store expansion program needs to reverse. At +4.8% YoY in Q1 FY2026, the company is adding customers slower than at any point in the filing set. If ARPC growth also normalizes - say, to 3-4% annually as the precision-progressives adoption cycle matures - the revenue growth deceleration implied by management's own FY2026 guidance (+10-12%, down from +13% and +15.2% in the prior two years) becomes the new normal rather than a transient step-down. That trajectory supports the Adjusted EBITDA margin expansion story but is difficult to reconcile with a GAAP operating income turnaround.

Section 6 - The macro environment

Warby Parker is navigating four macro forces simultaneously, and they are not pointing in the same direction.

The optical industry demand trend is structurally sound. Eyewear is a necessity purchase driven by prescription change cycles, aging demographics, and increasing screen time - not a consumer-sentiment-dependent discretionary category. The US has approximately 45,000 optical shops serving a population with persistent and growing vision-correction needs. Warby Parker's 337 stores represent a small fraction of that footprint, and the company's positioning at the $95-250 price point is below the mass-market national chain average, making it more accessible in a consumer-cautious environment than premium alternatives. The Vision Council's Q1 2026 consumer insights report noted that vision-care spending edged lower in early 2026 as consumers gravitated toward lower price points - a dynamic that arguably benefits Warby Parker's positioning relative to higher-end optical retailers.

Tariff exposure on Chinese-sourced frames is the most immediate cost-structure risk. The FY2025 10-K names China explicitly as a sourcing geography and the February 2025 tariff escalation as a known cost risk. Management has initiated supplier diversification - domestic optical lab investment is mentioned as one mitigation lever - but the 10-K's own risk factor language acknowledges the transition timeline: "port of entry risks such as longshoremen strikes, import restrictions, foreign government regulations, trade restrictions, customs, and duties." The Canada/Mexico tariff threat (subsequently paused) adds a secondary layer of exposure through the company's five Canadian stores and any North American supply chain linkages. None of this is existential; all of it is a headwind that lands directly in COGS before gross margin can recover.

The co-CEO structure carries key-person concentration risk that is not typical for a company of this scale. Neil Blumenthal (brand and product) and Dave Gilboa (strategy and capital) have been co-CEOs since the company's founding in 2010. The FY2025 10-K identifies this as a risk factor: succession depth is not publicly disclosed. For a company with $286M of cash, 323 retail leases, and a $100M share repurchase authorization outstanding, the execution and cultural continuity embedded in the co-founder relationship is a real non-diversifiable exposure. The appointment of a new CFO - Adrian Mitchell, effective February 10, 2026, formerly COO and CFO of Macy's - is a positive signal for financial discipline, but it is a first step into a more conventional management structure, not a succession resolution.

The AI eyewear category, if it develops as EssilorLuxottica's Ray-Ban Meta data suggests, is a genuine category-level tailwind. Over 7M Ray-Ban Meta units sold as of EssilorLuxottica's FY2025 commentary represents a proven consumer appetite for smart glasses - and Ray-Ban Meta is a fashion sunglasses product without prescription capability. A Warby Parker/Google product with prescription AI glasses would be differentiated from everything currently in market. The category creation risk is real (consumer adoption of new form factor), but the competitive moat if it succeeds is also real: Warby Parker's optometry network and prescription lens manufacturing capability are not things a tech company can replicate quickly.

Section 7 - The CFO verdict and the operator bridge

Here is the read on Warby Parker from a CFO's vantage point.

The brand is legitimate. The pricing power is documentable across three years of ARPC data. The cash position is genuinely strong. The Active Customer base on a 2-year replenishment cycle provides a revenue floor that most DTC brands do not have. If you are underwriting the brand - the customer loyalty, the NPS, the #glasseshaul organic content, the "Buy a Pair Give a Pair" mission alignment - you can build a compelling case that Warby Parker at 337 stores is an early innings story with 500+ additional locations ahead of it.

The problem is the same problem it has been for 15 years: the company cannot yet demonstrate that the business model earns money at the operating level on a full-year GAAP basis. The FY2025 EPS of $0.01 was produced by interest income from the cash pile offsetting the operating loss - not by operations. The march from -$144M to -$5M in operating loss was almost entirely SG&A efficiency from the Founders Grant wind-down. That program is done. The FY2026 Adjusted EBITDA guide implies management expects further SG&A efficiency - but the rate of improvement is slowing, gross margin is under tariff pressure, and the next 50 stores are adding to the fixed-cost base before they mature.

As we discussed in our Hims & Hers teardown, the question for any DTC brand approaching GAAP profitability is whether the improvement is structural or mechanical. Warby Parker's improvement to date has been primarily mechanical - the Founders Grant unwinding, not store-level economics compounding. But the obvious next question - "can they get gross margin back to 55%+?" - is the wrong one, and the Street agrees: in-store doctor payroll and occupancy sit in COGS, the exam-and-contacts mix is a deliberate LTV trade, and the $95 price is a 16-year moat, not a lever to raise. Analysts value WRBY off Adjusted EBITDA (12.2%), free cash flow, and per-store contribution, with a price-target spread from $19 (Morgan Stanley) to $35 (Baird) that is entirely about growth durability and the Google AI-glasses optionality, not margin. Here is where our read is sharper than the consensus: the real crack is not margin, it is that e-commerce - the channel Warby invented - shrank 4.1% in Q1 FY2026, leaving the whole growth case resting on store productivity not saturating. That, plus free-cash-flow inflection as the store build-out normalizes, is the structural question that remains unanswered. Gross margin is a distraction from it.

The verdict, sourced and pointed: a beloved brand with real pricing power that, 15 years in, still has not proven it can make money on a full-year GAAP basis - and the easy SG&A wins are now spent.

The operator bridge. Your $5-80M DTC or omnichannel brand very likely has a version of this pattern - smaller in magnitude, but structurally identical. The tell is this: the thing carrying your profitability march right now is probably SG&A efficiency, not gross margin, and SG&A efficiency has a floor. But the wrong response, the one a value-investor ratio screen or an anxious board will push you toward, is "now go raise gross margin." Sometimes you can't, and sometimes you shouldn't: if your margin is compressing because you are deliberately adding a lower-first-order-margin but higher-LTV line (a service, a consumable, a subscription), or opening locations whose fixed cost lands in COGS before they mature, that compression is investing ahead of harvest, not erosion. The discipline is knowing which one you are looking at - and the only way to know is to manage to contribution margin per cohort and free cash flow, not the consolidated gross-margin headline.

I have seen both versions in client work. In one, a brand's margin was compressing because each new cohort genuinely cost more to serve and the contribution margin per order was deteriorating - real erosion, caught late because a growing top line hid it. In another, the headline gross margin was falling but every new cohort's contribution margin and payback were healthy and improving, and the founder was being told to "fix margin" when the right move was to keep investing and watch free cash flow. The two look identical on the consolidated gross-margin line. They are opposite businesses. The early warning is not the gross-margin percentage at all - it is contribution margin per cohort and whether free cash flow is inflecting as the investment normalizes.

Early-warning scorecard - five lines that catch this 12 months early:

1. Contribution margin per cohort, not headline gross margin: a compressing consolidated gross margin can mean deliberate LTV investment (healthy) or genuine erosion (dangerous), and they look identical on the P&L. Split it: is each new cohort's contribution margin, after the cost to serve, holding or improving? If yes, the compression is investment; if no, it is erosion. Do not let the headline number trigger a "raise margin" reflex before you know which.
2. SG&A as % of revenue YoY improvement rate: when the improvement rate slows materially (Warby Parker: SG&A efficiency fell from -6.1 ppts in FY2023 to -4.6 ppts in FY2024 to -0.0 ppts estimated in FY2026), the one-time cost savings are nearly exhausted. The next improvement has to come from the units maturing - store cohorts hitting their contribution targets and the high-LTV mix compounding - not from squeezing the headline gross margin.
3. ARPC direction vs. Active Customer growth: when ARPC grows faster than Active Customer count, your existing customers are buying more - that is the model working. When Active Customer growth decelerates while ARPC growth holds (as in Q1 FY2026: +4.8% customers, +6.9% ARPC), the growth is increasingly dependent on extracting more from fewer new people. That has a ceiling.
4. Operating cash flow vs. capex: when OCF ($110.8M in FY2025) covers capex ($67.0M in FY2025) with room to spare, the business self-funds its expansion. When 50 new stores require $65-75M of capex annually, check whether OCF is growing at the same rate or faster. If it is not, cash reserves are covering the gap.
5. Inventory days outstanding trend: Warby Parker's inventory fell from $68.8M (FY2022) to $44.5M (FY2025) as the model tightened - a positive signal. Watch for any inflection upward relative to revenue growth pace, which would flag demand softening before it shows in the top line.

If you want to run this scorecard against your own numbers - whether you are approaching a board conversation about profitability, planning a raise, or trying to explain why the operating loss is not improving as fast as revenue is growing - that is a fractional CFO conversation. The analysis takes a few hours. The cost of not doing it arrives in the quarter you discover your margin was eroding when you thought you were investing - or that you starved a healthy investment because a ratio screen told you to "fix the margin."

Sources and methodology

SEC EDGAR is the primary source for every financial figure in this post. Warby Parker Inc. (CIK 0001504776) files on SEC EDGAR under the 10-K and 10-Q form types. The specific filings used: 10-K FY2025 (filed 2026-02-26, accession 000150477626000006); 10-Q Q1 FY2026 (filed 2026-05-07, accession 000150477626000011); 10-K FY2024 (filed 2025-02-27, accession 000150477625000010); 10-K FY2023 (filed 2024-02-29, accession 000150477624000006). Revenue, gross margin, operating income (loss), diluted EPS, operating cash flow, capex, SG&A, inventory, cash, and balance sheet figures are taken directly from XBRL financial statements in these filings.

ARPC and Active Customer figures are reported by management in the MD&A section of each annual 10-K and in quarterly earnings press releases (businesswire.com, 2025-08-06, 2025-11-06, 2026-02-26, 2026-05-07). The ARPC of $331 in Q1 FY2026 is from the Q1 FY2026 earnings press release (businesswire.com, 2026-05-07) and is on a trailing 12-month basis consistent with how management reports this metric.

Our research provided the business model analysis, strengths and weaknesses analysis, competitive map, and macro environment commentary. All figures were cross-referenced against SEC filings before inclusion.

The analyst and pundit thesis layer (published analyst research and sell-side notes) was used to vet our read against the Street's. It established that the sell-side debate (price-target spread $19 Morgan Stanley to $35 Baird) centres on growth durability and the Google AI-glasses optionality, not gross margin; that analysts value WRBY off Adjusted EBITDA (12.2% in Q1 FY2026), free cash flow, and per-store contribution; and that the common "raise gross margin" prescription is a value-investor ratio-screen lens (StockStory's lone Underperform) that the structure of the business contradicts. Sources include the Q1 FY2026 earnings call transcript (Seeking Alpha / The Motley Fool, May 7-8, 2026), Finaloop's margin analysis (Dec 2024), the ValueInvestorsClub bull case (Feb 3, 2026), and Seeking Alpha's Dec 17, 2025 downgrade. These are synthesized commentary and opinion, attributed as such, not filing fact. The quarterly gross margin table (Q2 FY2024 through Q1 FY2026) and the Active Customer quarterly data are sourced to individual quarterly earnings press releases.

The Google/Samsung AI glasses partnership is sourced exclusively to the FY2025 10-K Item 1A (verbatim: "We are also developing products and services that integrate AI, such as the AI-powered smart glasses we are developing with Google.") and the co-CEO CNBC appearance (May 2026, TikTok @cnbc embed above). The financial terms are partly disclosed in the Q1 FY2026 10-Q: Google committed to reimburse up to $75M of Warby Parker's development and commercialization costs and to invest up to a further $75M in equity at Warby Parker's option, subject to milestones. Warby Parker had incurred $5.3M of reimbursable costs through March 31, 2026, with $2.0M offset against SG&A in the quarter. The revenue timeline, margin profile, and unit economics of any resulting product remain undisclosed.

Founders Grant stock-compensation details are sourced to the FY2024 10-K MD&A, which discloses a $23.2M year-over-year reduction in SBC attributable to the wind-down, and the FY2025 10-K which confirms the program is "substantially completed." The FY2025 10-K reports total SBC of $36.1M and the Q1 FY2026 10-Q reports $12.0M of SBC in the quarter (4.95% of revenue).

EssilorLuxottica competitive references are sourced to EssilorLuxottica Q4/Full Year FY2025 press release (Feb 2026, essilorluxottica.com): adjusted operating margin 16.0%, FY revenue Euro 28.5B, Ray-Ban Meta "passed 7 million units sold," retail network approximately 20,000 locations. The Costco Optical $1.798B US optical revenue figure is from Vision Monday's 2025 Top 50 US Optical Retailers list (visionmonday.com, PDF, 2025).

TikTok content is social signal only and carries no financial claim. @dmv.speechie (76.9K plays, organic glasses haul), @aaliyaseika (43K plays, frame haul, 4,009 likes), and @cnbc (103.7K plays, co-CEO Dave Gilboa CNBC interview on Google AI glasses, May 2026) were selected as illustrative social signal. Engagement figures are at time of data collection.

Limitations. Warby Parker does not disclose a revenue split between e-commerce and retail stores in any filing reviewed. The company is a single reportable segment. The Target shop-in-shops partnership (reported by Business of Fashion, 2025) is not confirmed in the FY2025 10-K as a material distribution arrangement; it is referenced in our competitive research but excluded from the financial analysis sections. Q4 FY2025 gross margin of 52.4% and quarterly Adjusted EBITDA figures for individual quarters are sourced to quarterly earnings releases, not independently confirmed via XBRL. This post reflects filings and disclosures current through June 23, 2026.

Frequently asked questions

has warby parker ever been profitable?

Warby Parker has never posted a positive full-year GAAP operating income in its history as a public company. Operating loss compressed from -$143.7M (FY2021) to -$5.3M (FY2025). Diluted EPS turned to $0.01 in FY2025 for the first time - technically positive - but only because approximately $8-10M of annual interest income from its $286M cash pile offset the operating loss. On a pure operating basis, the company remains in the red at the GAAP level. Adjusted EBITDA was $95.2M in FY2025 (10.9% margin), but Adjusted EBITDA excludes $36.1M of stock-based compensation and other non-cash items.

why is warby parker's gross margin declining?

Warby Parker's gross margin fell from 57.0% (FY2022) to 54.0% (FY2025), a 300-basis-point compression over three years. The drivers are structural: contacts and eye care revenue growing faster than eyewear (both carry lower gross margins); doctor headcount and exam-room build-out adding to cost of goods; and, since early 2025, explicit tariff costs on Chinese-sourced frame components. The FY2025 10-K states verbatim: "We source components from suppliers located in China." Q4 FY2025 and Q1 FY2026 both attributed gross margin compression to "tariff costs related to glasses." The FY2024 uptick to 55.3% was a one-year exception driven by faster growth in eyewear vs. contacts.

what is the warby parker google ai glasses partnership?

The FY2025 10-K disclosed for the first time that Warby Parker is developing AI-powered smart glasses with Google and Samsung. The verbatim 10-K language: "We are also developing products and services that integrate AI, such as the AI-powered smart glasses we are developing with Google." The Q1 FY2026 10-Q discloses the partnership economics: Google will reimburse up to $75M of development and commercialization costs and may invest up to $75M in equity at Warby Parker's option ($2.0M was offset against SG&A in the quarter; $5.3M of reimbursable costs incurred through March 31, 2026). The revenue timeline, margin profile, and unit economics remain undisclosed. Co-CEO Dave Gilboa discussed the partnership publicly in May 2026 (CNBC Squawk Box). Whether AI glasses expand or cannibalize Warby Parker's core $95 prescription frame business, and what the margin profile looks like relative to the current 54% gross margin, are not questions the filing answers.

how many warby parker stores are there and what is the target?

As of March 31, 2026, Warby Parker operated 337 stores. Management has guided for approximately 50 net new stores in FY2026, which would bring the total to roughly 370-375. The company has internally sized the US opportunity at over 900 potential locations, suggesting the current footprint has penetrated roughly 37% of the long-term target. However, 65% or more of the existing fleet was opened in the last five years, meaning most stores are still in early maturation. Each new store carries multi-year lease obligations and doctor headcount costs before reaching contribution-margin maturity. Source: WRBY 10-K FY2025; Q1 FY2026 earnings release.

what is warby parker's average revenue per customer?

Average Revenue per Active Customer (ARPC) was $324 in FY2025, up from $307 in FY2024, $287 in FY2023, and $263 in FY2022 - a 23% expansion in three years. As of Q1 FY2026, ARPC on a trailing 12-month basis was approximately $331. The drivers: adoption of precision progressives (higher ASP), contacts bundling following in-store eye exams, and selective retail price increases implemented in Q2 FY2025. ARPC is the clearest documented evidence of pricing power in the Warby Parker filing set. Source: WRBY 10-K FY2025; Q1 FY2026 earnings release.

does warby parker have debt?

No funded long-term debt. At March 31, 2026: $288.2M in cash and short-term investments, $0 drawn on a $120M JPMorgan revolving credit facility (expandable to $175M), with only $4.3M in letters of credit drawn to secure retail leases. The real balance-sheet claim is operating lease liabilities: approximately $237.6M total at March 31, 2026, reflecting 337 retail leases on 10+ year terms. Adding 50 stores per year compounds this figure. The company also has a $100M share repurchase authorization approved February 2026, with zero shares repurchased as of Q1 FY2026. Source: WRBY 10-K FY2025; 10-Q Q1 FY2026.

who are warby parker's main competitors?

EssilorLuxottica is the global incumbent (Ray-Ban, LensCrafters, EyeMed), operating nearly 20,000 retail locations globally and generating Euro 28.5B in FY2025 revenue. Zenni Optical is the online-first value disruptor. Costco Optical reported approximately $1.8B in US optical revenue in 2024 across roughly 588 locations. National Vision and America's Best are mass-channel alternatives in the $99-$149 range. Warby Parker positions between value (Zenni, Costco) and premium (EssilorLuxottica-affiliated), at $95-250 per frame with a differentiated brand and owned optical labs. Its 337 stores as of Q1 FY2026 represent approximately 0.7% of the roughly 45,000 optical shops in the US market. Source: WRBY 10-K FY2025; EssilorLuxottica FY2025 results; Vision Monday Top 50 US Optical Retailers 2025.